
Mr. Riva became President, Chief Executive Officer and Director of Verenium in June of 2007, after the merger of Diversa and Celunol closed. Carlos joined Celunol as Chief Executive Officer in 2006. Prior to joining Celunol, from 2003 to 2005 he served as Executive Director of Amec plc, a major global construction and engineering company based in the U.K., where he was responsible for the company’s operations in the United States and Britain and for Amec’s global oil and gas business strategy. From 1995 to 2003, Mr. Riva was Chief Executive Officer of InterGen, a Boston-based joint venture between Shell and Bechtel that developed more than 17,000 megawatts of electric generating capacity, along with gas storage and pipelines, on six continents. Under his leadership InterGen raised more than $9 billion of non-recourse project financing to construct power projects and grew from a development company concept to a successful, global operating business. From 1992 to 1994 Mr. Riva was President and Chief Operating Officer of Boston-based J. Makowski Company, which developed the first independent power project in the United States. Mr. Riva received his B.S. and M.S. degrees in Civil Engineering from M.I.T. and Stanford University respectively, and an M.B.A. from the Harvard Business School.

Mr. McCarthy became Executive Vice President and Chief Financial Officer in June of 2007, after the merger of Diversa and Celunol closed. He joined Celunol in November 2006 as Executive Vice President and Chief Financial Officer. He spent the previous 15 years in the healthcare/life sciences industry, focused on managing the transformational growth of early-stage companies into diversified entities. He led three companies through the IPO process, raising over $375 million in the private and public capital markets. Mr. McCarthy's experience includes serving as SVP & CFO of Xanthus Pharmaceuticals, SVP Corporate Development & CFO of Synta Pharmaceuticals, EVP & CFO of Exact Sciences, and President of the Managed Care Services Division of Concentra Managed Care. Prior to his operating career, Mr. McCarthy worked in the Investment Banking Division of Morgan Stanley in New York. Mr. McCarthy graduated with a BS from Lehigh University and received his MBA degree from Harvard Business School.



Mr. John R. Malloy, Jr. became Executive Vice President, Biofuels in June of 2007, after the merger of Diversa and Celunol closed. He is responsible for Verenium's Biofuels business unit. Before joining Celunol in 2005, he was President and Chief Executive Officer of Predictive Power and Chief Operating Officer of Wilson TurboPower, both early stage, venture-backed MIT energy technology start-up companies. Previously he had been responsible for business, corporate and project development for Citizens Lehman Power and for Edison Mission Marketing & Trading after its purchase of Citizens Lehman Power. He had also been Chief Operating Officer of Beacon Energy Company, Project Vice President of Wheelabrator Technologies, and Director of Project Development of U.S. Generating Company. Mr. Malloy received a BSME from the University of Massachusetts and an SMME from MIT.
Mr. William H. Baum, in addition to his Executive Vice President role, became General Manager, Specialty Enzymes in June of 2007, after the merger of Diversa and Celunol closed. He joined Diversa in August 1997 as Vice President, Sales and Marketing, and was promoted to Senior Vice President, Business Development in November 1999 and to Executive Vice President, Chemical, Agriculture, and Industrial Enzymes Business in July 2002. Mr. Baum was Vice President of Global Sales and Marketing with International Specialty Products, a specialty chemical company, from 1993 to 1997. Prior to joining International Specialty, Mr. Baum was with Betz Laboratories, also a specialty chemical company, for 20 years in a variety of international and domestic executive management positions, including Executive Vice President of European Operations and as Managing Director of Betz GmbH. Mr. Baum received a B.S. from Widener University.
|
|